Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression

American Journal of Physiology - Cell Physiology

Volumn 291, Issue 5, 2006, Pages

  Searles, Charles D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3 untranslated region; Endothelium; Gene regulation; mRNA stability; Transcription

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; CYCLOSPORIN A; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROGEN PEROXIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LINOLEIC ACID; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; THROMBIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

3' UNTRANSLATED REGION; CELL FUNCTION; CELL GROWTH; DNA POLYMORPHISM; GENE CONTROL; GENETIC TRANSCRIPTION; HYPOXIA; IN VIVO STUDY; MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; VASCULAR DISEASE;

3' UNTRANSLATED REGIONS; ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOMEOSTASIS; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

EID: 33751104228     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00457.2005     Document Type: Review

References (157)

1. Alheid U, Frolich JC, and Forstermann U. Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets. Thromb Res 47: 561-571, 1987.
2. Alonso J, Sanchez de Miguel L, Monton M, Casado S, and Lopez-Farre A. Endothelial cytosolic proteins bind to the 3′ untranslated region of endothelial nitric oxide synthase mRNA: regulation by tumor necrosis factor α. Mol Cell Biol 17: 5719-5726, 1997.
3. Anderson HD, Rahmutula D, and Gardner DG. Tumor necrosis factor-α inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. J Biol Chem 279: 963-969, 2004.
4. Aoki N, Siegfried M, and Lefer AM. Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries. Am J Physiol Heart Circ Physiol 256: H1509-H1512, 1989.
5. Arnal JF, Yamin J, Dockery S, and Harrison DG. Regulation of endothelial nitric oxide synthase mRNA, protein, and activity during cell growth. Am J Physiol Cell Physiol 267: C1381-C1388, 1994.
6. Arnet UA, McMillan A, Dinerman JL, Ballermann B, and Lowenstein CJ. Regulation of endothelial nitric-oxide synthase during hypoxia. J Biol Chem 271: 15069-15073, 1996.
7. Arriero MM, de La Pinta JC, Escribano M, Celdran A, Munoz-Alameda L, Garcia-Canete J, Jimenez AM, Casado S, Farre J, and Lopez-Farre A. Aspirin prevents Escherichia coli lipopolysaccharide- and Staphylococcus aureus-induced downregulation of endothelial nitric oxide synthase expression in guinea pig pericardial tissue. Circ Res 90: 719-727, 2002.
8. Bauersachs J, Bouloumie A, Fraccarollo D, Hu K, Busse R, and Ertl G. Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation 100: 292-298, 1999.
9. Black SM, Fineman JR, Steinhorn RH, Bristow J, and Soifer SJ. Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Heart Circ Physiol 275: H1643-H1651, 1998.
10. Bobadilla NA, Gamba G, Tapia E, Garcia-Torres R, Bolio A, Lopez-Zetina P, and Herrera-Acosta J. Role of NO in cyclosporin nephrotoxicity: effects of chronic NO inhibition and NO synthases gene expression. Am J Physiol Renal Physiol 274: F791-F798, 1998.
11. Bouloumie A, Bauersachs J, Linz W, Scholkens BA, Wiemer G, Fleming I, and Busse R. Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension 30: 934-941, 1997.
12. Cai H, Davis ME, Drummond GR, and Harrison DG. Induction of endothelial NO synthase by hydrogen peroxide via a Ca(2+)/calmodulin-dependent protein kinase II/janus kinase 2-dependent pathway. Arterioscler Thromb Vasc Biol 21: 1571-1576, 2001.
13. Cai H, McNally JS, Weber M, and Harrison DG. Oscillatory shear stress upregulation of endothelial nitric oxide synthase requires intracellular hydrogen peroxide and CaMKII. J Mol Cell Cardiol 37: 121-125, 2004.
14. Chan Y, Fish JE, D'Abreo C, Lin S, Robb GB, Teichert AM, Karantzoulis-Fegaras F, Keightley A, Steer BM, and Marsden PA. The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation. J Biol Chem 279: 35087-35100, 2004.
15. Cheng CP, Herfkens RJ, and Taylor CA. Abdominal aortic hemodynamic conditions in healthy subjects aged 50-70 at rest and during lower limb exercise: in vivo quantification using MRI. Atherosclerosis 168: 323-331, 2003.
16. Chung HT, Pae HO, Choi BM, Billiar TR, and Kim YM. Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 282: 1075-1079, 2001.
17. Cieslik K, Abrams CS, and Wu KK. Up-regulation of endothelial nitric-oxide synthase promoter by the phosphatidylinositol 3-kinase gamma/Janus kinase 2/MEK-1-dependent pathway. J Biol Chem 276: 1211-1219, 2001.
18. Cieslik K, Lee CM, Tang JL, and Wu KK. Transcriptional regulation of endothelial nitric-oxide synthase by an interaction between casein kinase 2 and protein phosphatase 2A. J Biol Chem 274: 34669-34675, 1999.
19. Cieslik K, Zembowicz A, Tang JL, and Wu KK. Transcriptional regulation of endothelial nitric-oxide synthase by lysophosphatidylcholine. J Biol Chem 273: 14885-14890, 1998.
20. Coulet F, Nadaud S, Agrapart M, and Soubrier F. Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter. J Biol Chem 278: 46230-46240, 2003.
21. Davis ME, Cai H, Drummond GR, and Harrison DG. Shear stress regulates endothelial nitric oxide synthase expression through c-Src by divergent signaling pathways. Circ Res 89: 1073-1080, 2001.
22. Davis ME, Cai H, McCann L, Fukai T, and Harrison DG. Role of c-Src in regulation of endothelial nitric oxide synthase expression during exercise training. Am J Physiol Heart Circ Physiol 284: H1449-H1453, 2003.
23. Davis ME, Grumbach IM, Fukai T, Cutchins A, and Harrison DG. Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor κB binding. J Biol Chem 279: 163-168, 2004.
24. Dekker RJ, van Soest S, Fontijn RD, Salamanca S, de Groot PG, VanBavel E, Pannekoek H, and Horrevoets AJ. Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kruppel-like factor (KLF2). Blood 100: 1689-1698, 2002.
25. Deroanne CF, Bonjean K, Servotte S, Devy L, Colige A, Clausse N, Blacher S, Verdin E, Foidart JM, Nusgens BV, and Castronovo V. Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling. Oncogene 21: 427-436, 2002.
26. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, and Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601-605, 1999.
27. Drummond GR, Cai H, Davis ME, Ramasamy S, and Harrison DG. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res 86: 347-354, 2000.
28. Ducrocq C, Blanchard B, Pignatelli B, and Ohshima H. Peroxynitrite: an endogenous oxidizing and nitrating agent. Cell Mol Life Sci 55: 1068-1077, 1999.
29. Eto M, Barandier C, Rathgeb L, Kozai T, Joch H, Yang Z, and Luscher TF. Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase. Circ Res 89: 583-590, 2001.
30. Fish JE, Matouk CC, Rachlis A, Lin S, Tai SC, D'Abreo C, and Marsden PA. The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. J Biol Chem 280: 24824-24838, 2005.
31. Fleming I and Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 284: R1-R12, 2003.
32. Fleming I, Fisslthaler B, Dimmeler S, Kemp BE, and Busse R. Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res 88: E68-75, 2001.
33. Ford LP, Watson J, Keene JD, and Wilusz J. ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev 13: 188-201, 1999.
34. Forstermann U, Mugge A, Alheid U, Bode SM, and Frolich JC. Endothelium-derived relaxing factor (EDRF): a defence mechanism against platelet aggregation and vasospasm in human coronary arteries. Eur Heart J 10, Suppl F: 36-43, 1989.
35. Fulton D, Gratton JP, and Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? J Pharmacol Exp Ther 299: 818-824, 2001.
36. Gallie DR. A tale of two termini: a functional interaction between the termini of an mRNA is a prerequisite for efficient translation initiation. Gene 216: 1-11, 1998.
37. Gan Y, Shen YH, Utama B, Wang J, Coselli J, and Wang XL. Dual effects of histone deacetylase inhibition by trichostatin A on endothelial nitric oxide synthase expression in endothelial cells. Biochem Biophys Res Commun 340: 29-34, 2006.
38. Gan Y, Shen YH, Wang J, Wang X, Utama B, and Wang XL. Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase. J Biol Chem 280: 16467-16475, 2005.
39. Garg UC and Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777, 1989.
40. Gnanapandithen K, Chen Z, Kau CL, Gorczynski RM, and Marsden PA. Cloning and characterization of murine endothelial constitutive nitric oxide synthase. Biochim Biophys Acta 1308: 103-106, 1996.
41. Goldstein JL and Brown MS. Regulation of the mevalonate pathway. Nature 343: 425-430, 1990.
42. Gonzalez-Fernandez F, Jimenez A, Lopez-Blaya A, Velasco S, Arriero MM, Celdran A, Rico L, Farre J, Casado S, and Lopez-Farre A. Cerivastatin prevents tumor necrosis factor-α-induced downregulation of endothelial nitric oxide synthase: role of endothelial cytosolic proteins. Atherosclerosis 155: 61-70, 2001.
43. Govers R and Rabelink TJ. Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol 280: F193-F206, 2001.
44. Grumbach IM, Chen W, Mertens SA, and Harrison DG. A negative feedback mechanism involving nitric oxide and nuclear factor κ-B modulates endothelial nitric oxide synthase transcription. J Mol Cell Cardiol, 2005.
45. Grzybowska EA, Wilczynska A, and Siedlecki JA. Regulatory functions of 3′UTRs. Biochem Biophys Res Commun 288: 291-295, 2001.
46. Hall A. Rho GTPases and the actin cytoskeleton. Science 279: 509-514, 1998.
47. Harrison DG. Endothelial control of vasomotion and nitric oxide production: a potential target for risk factor management. Cardiol Clin 14: 1-15, 1996.
48. Hernandez-Perera O, Perez-Sala D, Navarro-Antolin J, Sanchez-Pascuala R, Hernandez G, Diaz C, and Lamas S. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 101: 2711-2719, 1998.
49. Hesketh JE. Sorting of messenger RNAs in the cytoplasm: mRNA localization and the cytoskeleton. Exp Cell Res 225: 219-236, 1996.
50. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, and Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88: E14-22, 2001.
51. 50a. Hirata K, Miki N, Kurada Y, Sadoka T, Kawashima S, and Yokoyama M. Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells. Circ Res 76: 958-962, 1995.
52. Hoffmann A, Gloe T, and Pohl U. Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: a comparison between hypoxia and inhibitors of cell metabolism. J Cell Physiol 188: 33-44, 2001.
53. Hughes MN. Relationships between nitric oxide, nitroxyl ion, nitrosonium cation and peroxynitrite. Biochim Biophys Acta 1411: 263-272, 1999.
54. Inoue N, Venema RC, Sayegh HS, Ohara Y, Murphy TJ, and Harrison DG. Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-beta 1. Arterioscler Thromb Vasc Biol 15: 1255-1261, 1995.
55. Jaenisch R and Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33 Suppl: 245-254, 2003.
56. Jimenez A, Arriero MM, Lopez-Blaya A, Gonzalez-Fernandez F, Garcia R, Fortes J, Millas I, Velasco S, Sanchez De Miguel L, Rico L, Farre J, Casado S, and Lopez-Farre A. Regulation of endothelial nitric oxide synthase expression in the vascular wall and in mononuclear cells from hypercholesterolemic rabbits. Circulation 104: 1822-1830, 2001.
57. Jourd'heuil D, Jourd'heuil FL, Kutchukian PS, Musah RA, Wink DA, and Grisham MB. Reaction of superoxide and nitric oxide with peroxynitrite. Implications for peroxynitrite-mediated oxidation reactions in vivo. J Biol Chem 276: 28799-28805, 2001.
58. Kano H, Hayashi T, Sumi D, Esaki T, Asai Y, Thakur NK, Jayachandran M, and Iguchi A. A HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels: possible relevance of up-regulation of endothelial NO synthase mRNA. Biochem Biophys Res Commun 259: 414-419, 1999.
59. Karantzoulis-Fegaras F, Antoniou H, Lai SL, Kulkarni G, D'Abreo C, Wong GK, Miller TL, Chan Y, Atkins J, Wang Y, and Marsden PA. Characterization of the human endothelial nitric-oxide synthase promoter. J Biol Chem 274: 3076-3093, 1999.
60. Kim MS, Kwon HJ, Lee YM, Baek JH, Jang JE, Lee SW, Moon EJ, Kim HS, Lee SK, Chung HY, Kim CW, and Kim KW. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 7: 437-443, 2001.
61. Klose R and Bird A. Molecular biology. MeCP2 repression goes nonglobal. Science 302: 793-795, 2003.
62. Kojda G, Cheng YC, Burchfield J, and Harrison DG. Dysfunctional regulation of endothelial nitric oxide synthase (eNOS) expression in response to exercise in mice lacking one eNOS gene. Circulation 103: 2839-2844, 2001.
63. Kubes P, Suzuki M, and Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88: 4651-4655, 1991.
64. Kugiyama K, Sugiyama S, Ogata N, Oka H, Doi H, Ota Y, and Yasue H. Burst production of superoxide anion in human endothelial cells by lysophosphatidylcholine. Atherosclerosis 143: 201-204, 1999.
65. Kume N, Cybulsky MI, and Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 90: 1138-1144, 1992.
66. Kume N and Gimbrone MA Jr. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 93: 907-911, 1994.
67. Lai PF, Mohamed F, Monge JC, and Stewart DJ. Downregulation of eNOS mRNA expression by TNFα: identification and functional characterization of RNA-protein interactions in the 3′UTR. Cardiovasc Res 59: 160-168, 2003.
68. Lassegue B and Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285: R277-R297, 2003.
69. Laude K, Cai H, Fink B, Hoch N, Weber DS, McCann L, Kojda G, Fukai T, Schmidt HH, Dikalov S, Ramasamy S, Gamez G, Griendling KK, and Harrison DG. Hemodynamic and biochemical adaptations to vascular smooth muscle overexpression of p22phox in mice. Am J Physiol Heart Circ Physiol 288: H7-H12, 2005.
70. Laufs U, Endres M, Stagliano N, Amin-Hanjani S, Chui DS, Yang SX, Simoncini T, Yamada M, Rabkin E, Allen PG, Huang PL, Bohm M, Schoen FJ, Moskowitz MA, and Liao JK. Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest 106: 15-24, 2000.
71. Laufs U, Fata VL, and Liao JK. Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. J Biol Chem 272: 31725-31729, 1997.
72. Laufs U, La Fata V, Plutzky J, and Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97: 1129-1135, 1998.
73. Laufs U and Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 273: 24266-24271, 1998.
74. Laumonnier Y, Nadaud S, Agrapart M, and Soubrier F. Characterization of an upstream enhancer region in the promoter of the human endothelial nitric-oxide synthase gene. J Biol Chem 275: 40732-40741, 2000.
75. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, and Harrison DG. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103: 1282-1288, 2001.
76. Le Cras TD, Tyler RC, Horan MP, Morris KG, Tuder RM, McMurtry IF, Johns RA, and Abman SH. Effects of chronic hypoxia and altered hemodynamics on endothelial nitric oxide synthase expression in the adult rat lung. J Clin Invest 101: 795-801, 1998.
77. Li H, Wallerath T, and Forstermann U. Physiological mechanisms regulating the expression of endothelial-type NO synthase. Nitric Oxide 7: 132-147, 2002.
78. Li H, Wallerath T, Munzel T, and Forstermann U. Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. Nitric Oxide 7: 149-164, 2002.
79. Liao JK, Shin WS, Lee WY, and Clark SL. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 270: 319-324, 1995.
80. Liao JK, Zulueta JJ, Yu FS, Peng HB, Cote CG, and Hassoun PM. Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen. J Clin Invest 96: 2661-2666, 1995.
81. Liebhaber SA. mRNA stability and the control of gene expression. Nucleic Acids Symp Ser: 29-32, 1997.
82. Liu SF, Adcock IM, Old RW, Barnes PJ, and Evans TW. Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat. Crit Care Med 24: 1219-1225, 1996.
83. Lopez-Ongil S, Hernandez-Perera O, Navarro-Antolin J, Perez de Lema G, Rodriguez-Puyol M, Lamas S, and Rodriguez-Puyol D. Role of reactive oxygen species in the signalling cascade of cyclosporine A-mediated up-regulation of eNOS in vascular endothelial cells. Br J Pharmacol 124: 447-454, 1998.
84. Lopez-Ongil S, Saura M, Rodriguez-Puyol D, Rodriguez-Puyol M, and Lamas S. Regulation of endothelial NO synthase expression by cyclosporin A in bovine aortic endothelial cells. Am J Physiol Heart Circ Physiol 271: H1072-H1078, 1996.
85. Lu JL, Schmiege LM III, Kuo L, and Liao JC. Downregulation of endothelial constitutive nitric oxide synthase expression by lipopolysaccharide. Biochem Biophys Res Commun 225: 1-5, 1996.
86. Malek AM, Jiang L, Lee I, Sessa WC, Izumo S, and Alper SL. Induction of nitric oxide synthase mRNA by shear stress requires intracellular calcium and G-protein signals and is modulated by PI 3 kinase. Biochem Biophys Res Commun 254: 231-242, 1999.
87. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC, and Schappert KT. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268: 17478-17488, 1993.
88. Mattsson EJ, Kohler TR, Vergel SM, and Clowes AW. Increased blood flow induces regression of intimal hyperplasia. Arterioscler Thromb Vasc Biol 17: 2245-2249, 1997.
89. Mazumder B, Seshadri V, and Fox PL. Translational control by the 3′-UTR: the ends specify the means. Trends Biochem Sci 28: 91-98, 2003.
90. McQuillan LP, Leung GK, Marsden PA, Kostyk SK, and Kourembanas S. Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. Am J Physiol Heart Circ Physiol 267: H1921-H1927, 1994.
91. Miller VM, Aarhus LL, and Vanhoutte PM. Modulation of endothelium-dependent responses by chronic alterations of blood flow. Am J Physiol Heart Circ Physiol 251: H520-H527, 1986.
92. Miller VM and Vanhoutte PM. Enhanced release of endothelium-derived factor(s) by chronic increases in blood flow. Am J Physiol Heart Circ Physiol 255: H446-H451, 1988.
93. Mitchell P and Tollervey D. mRNA stability in eukaryotes. Curr Opin Genet Dev 10: 193-198, 2000.
94. Mohamed F, Monge JC, Gordon A, Cernacek P, Blais D, and Stewart DJ. Lack of role for nitric oxide (NO) in the selective destabilization of endothelial NO synthase mRNA by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 15: 52-57, 1995.
95. Moudgil R, Michelakis ED, and Archer SL. Hypoxic pulmonary vasoconstriction. J Appl Physiol 98: 390-403, 2005.
96. Murad F, Waldman S, Molina C, Bennett B, and Leitman D. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation. Prog Clin Biol Res 249: 65-76, 1987.
97. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, and Isner JM. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101: 2567-2578, 1998.
98. Myers PR, Minor RL Jr, Guerra R Jr, Bates JN, and Harrison DG. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345: 161-163, 1990.
99. Nadaud S, Philippe M, Arnal JF, Michel JB, and Soubrier F. Sustained increase in aortic endothelial nitric oxide synthase expression in vivo in a model of chronic high blood flow. Circ Res 79: 857-863, 1996.
100. Neumann P, Gertzberg N, and Johnson A. TNF-α induces a decrease in eNOS promoter activity. Am J Physiol Lung Cell Mol Physiol 286: L452-L459, 2004.
101. Nguyen CT, Gonzales FA, and Jones PA. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res 29: 4598-4606, 2001.
102. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, Alexander RW, and Murphy TJ. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 90: 2092-2096, 1992.
103. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614, 1992.
104. Ou H, Shen YH, Utama B, Wang J, Wang X, Coselli J, and Wang XL. Effect of nuclear actin on endothelial nitric oxide synthase expression. Arterioscler Thromb Vasc Biol 25: 2509-2514, 2005.
105. Parmar KM, Nambudiri V, Dai G, Larman HB, Gimbrone MA Jr, and Garcia-Cardena G. Statins exert endothelial atheroprotective effects via the KLF2 transcription factor. J Biol Chem 280: 26714-26719, 2005.
106. 2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci USA 82: 3000-3004, 1985.
107. Pepper MS. Transforming growth factor-β: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8: 21-43, 1997.
108. Pesole G, Mignone F, Gissi C, Grillo G, Licciulli F, and Liuni S. Structural and functional features of eukaryotic mRNA untranslated regions. Gene 276: 73-81, 2001.
109. Poppa V, Miyashiro JK, Corson MA, and Berk BC. Endothelial NO synthase is increased in regenerating endothelium after denuding injury of the rat aorta. Arterioscler Thromb Vasc Biol 18: 1312-1321, 1998.
110. Quinn MT, Parthasarathy S, and Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci USA 85: 2805-2809, 1988.
111. Ramasamy S, Parthasarathy S, and Harrison DG. Regulation of endothelial nitric oxide synthase gene expression by oxidized linoleic acid. J Lipid Res 39: 268-276, 1998.
112. Robb GB, Carson AR, Tai SC, Fish JE, Singh S, Yamada T, Scherer SW, Nakabayashi K, and Marsden PA. Post-transcriptional regulation of endothelial nitric-oxide synthase by an overlapping antisense mRNA transcript. J Biol Chem 279: 37982-37996, 2004.
113. Robertson KD and Wolffe AP. DNA methylation in health and disease. Nat Rev Genet 1: 11-19, 2000.
114. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809, 1993.
115. Rossig L, Li H, Fisslthaler B, Urbich C, Fleming I, Forstermann U, Zeiher AM, and Dimmeler S. Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis. Circ Res 91: 837-844, 2002.
116. Rubanyi GM and Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol Heart Circ Physiol 250: H822-H827, 1986.
117. Sachs A and Wahle E. Poly(A) tail metabolism and function in eucaryotes. J Biol Chem 268: 22955-22958, 1993.
118. Sanchez de Miguel L, Alonso J, Gonzalez-Fernandez F, de la Osada J, Monton M, Rodriguez-Feo JA, Guerra JI, Arriero MM, Rico L, Casado S, and Lopez-Farre A. Evidence that an endothelial cytosolic protein binds to the 3′-untranslated region of endothelial nitric oxide synthase mRNA. J Vasc Res 36: 201-208, 1999.
119. Sarzani R, Brecher P, and Chobanian AV. Growth factor expression in aorta of normotensive and hypertensive rats. J Clin Invest 83: 1404-1408, 1989.
120. Saura M, Zaragoza C, Cao W, Bao C, Rodriguez-Puyol M, Rodriguez-Puyol D, and Lowenstein CJ. Smad2 mediates transforming growth factor-beta induction of endothelial nitric oxide synthase expression. Circ Res 91: 806-813, 2002.
121. Schubeler D, Lorincz MC, Cimbora DM, Telling A, Feng YQ, Bouhassira EE, and Groudine M. Genomic targeting of methylated DNA: influence of methylation on transcription, replication, chromatin structure, and histone acetylation. Mol Cell Biol 20: 9103-9112, 2000.
122. Scorilas A. Polyadenylate polymerase (PAP) and 3′ end pre-mRNA processing: function, assays, and association with disease. Crit Rev Clin Lab Sci 39: 193-224, 2002.
123. Searles CD, Ide L, Davis ME, Cai H, and Weber M. Actin cytoskeleton organization and posttranscriptional regulation of endothelial nitric oxide synthase during cell growth. Circ Res 95: 488-495, 2004.
124. Searles CD, Miwa Y, Harrison DG, and Ramasamy S. Posttranscriptional regulation of endothelial nitric oxide synthase during cell growth. Circ Res 85: 588-595, 1999.
125. Sellke FW, Quillen JE, Brooks LA, and Harrison DG. Endothelial modulation of the coronary vasculature in vessels perfused via mature collaterals. Circulation 81: 1938-1947, 1990.
126. Sen-Banerjee S, Lin Z, Atkins GB, Greif DM, Rao RM, Kumar A, Feinberg MW, Chen Z, Simon DI, Luscinskas FW, Michel TM, Gimbrone MA Jr, Garcia-Cardena G, and Jain MK. KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med 199: 1305-1315, 2004.
127. Sen-Banerjee S, Mir S, Lin Z, Hamik A, Atkins GB, Das H, Banerjee P, Kumar A, and Jain MK. Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells. Circulation 112: 720-726, 2005.
128. Sessa WC, Pritchard K, Seyedi N, Wang J, and Hintze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 74: 349-353, 1994.
129. Shaul PW, North AJ, Brannon TS, Ujiie K, Wells LB, Nisen PA, Lowenstein CJ, Snyder SH, and Star RA. Prolonged in vivo hypoxia enhances nitric oxide synthase type I and type III gene expression in adult rat lung. Am J Respir Cell Mol Biol 13: 167-174, 1995.
130. Shen W, Zhang X, Zhao G, Wolin MS, Sessa W, and Hintze TH. Nitric oxide production and NO synthase gene expression contribute to vascular regulation during exercise. Med Sci Sports Exerc 27: 1125-1134, 1995.
131. Silacci P, Formentin K, Bouzourene K, Daniel F, Brunner HR, and Hayoz D. Unidirectional and oscillatory shear stress differentially modulate NOS III gene expression. Nitric Oxide 4: 47-56, 2000.
132. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ, and Loscalzo J. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 89: 444-448, 1992.
133. Stroes ES, Luscher TF, de Groot FG, Koomans HA, and Rabelink TJ. Cyclosporin A increases nitric oxide activity in vivo. Hypertension 29: 570-575, 1997.
134. Stuehr DJ. Mammalian nitric oxide synthases. Biochim Biophys Acta 1411: 217-230, 1999.
135. Sumi D, Hayashi T, Thakur NK, Jayachandran M, Asai Y, Kano H, Matsui H, and Iguchi A. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects - the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action. Atherosclerosis 155: 347-357, 2001.
136. Sun D, Huang A, Koller A, and Kaley G. Decreased arteriolar sensitivity to shear stress in adult rats is reversed by chronic exercise activity. Microcirculation 9: 91-97, 2002.
137. Tai SC, Robb GB, and Marsden PA. Endothelial nitric oxide synthase: a new paradigm for gene regulation in the injured blood vessel. Arterioscler Thromb Vasc Biol 24: 405-412, 2004.
138. Takemoto M, Sun J, Hiroki J, Shimokawa H, and Liao JK. Rhokinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation 106: 57-62, 2002.
139. Taylor CA, Cheng CP, Espinosa LA, Tang BT, Parker D, and Herfkens RJ. In vivo quantification of blood flow and wall shear stress in the human abdominal aorta during lower limb exercise. Ann Biomed Eng 30: 402-408, 2002.
140. Toporsian M, Govindaraju K, Nagi M, Eidelman D, Thibault G, and Ward ME. Downregulation of endothelial nitric oxide synthase in rat aorta after prolonged hypoxia in vivo. Circ Res 86: 671-675, 2000.
141. Topper JN, Cai J, Falb D, and Gimbrone MA Jr. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci USA 93: 10417-10422, 1996.
142. Uematsu M, Ohara Y, Navas JP, Nishida K, Murphy TJ, Alexander RW, Nerem RM, and Harrison DG. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am J Physiol Cell Physiol 269: C1371-C1378, 1995.
143. Van Aelst L and D'Souza-Schorey C. Rho GTPases and signaling networks. Genes Dev 11: 2295-2322, 1997.
144. Van der Loo B, Labugger R, Skepper JN, Bachschmid M, Kilo J, Powell JM, Palacios-Callender M, Erusalimsky JD, Quaschning T, Malinski T, Gygi D, Ullrich V, and Luscher TF. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med 192: 1731-1744, 2000.
145. Venema RC, Nishida K, Alexander RW, Harrison DG, and Murphy TJ. Organization of the bovine gene encoding the endothelial nitric oxide synthase. Biochim Biophys Acta 1218: 413-420, 1994.
146. Wang Z, Day N, Trifillis P, and Kiledjian M. An mRNA stability complex functions with poly(A)-binding protein to stabilize mRNA in vitro. Mol Cell Biol 19: 4552-4560, 1999.
147. Wattanapitayakul SK, Mihm MJ, Young AP, and Bauer JA. Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism. Trends Pharmacol Sci 22: 361-368, 2001.
148. Weber M, Hagedorn CH, Harrison DG, and Searles CD. Laminar shear stress and 3′ polyadenylation of eNOS mRNA. Circ Res 96: 1161-1168, 2005.
149. Wilcox JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG, and Marsden PA. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler Thromb Vasc Biol 17: 2479-2488, 1997.
150. Wink DA, Cook JA, Kim SY, Vodovotz Y, Pacelli R, Krishna MC, Russo A, Mitchell JB, Jourd'heuil D, Miles AM, and Grisham MB. Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. Chemical aspects involved in the balance between oxidative and nitrosative stress. J Biol Chem 272: 11147-11151, 1997.
151. Wolfrum S, Grimm M, Heidbreder M, Dendorfer A, Katus HA, Liao JK, and Richardt G. Acute reduction of myocardial infarct size by a hydroxymethyl glutaryl coenzyme a reductase inhibitor is mediated by endothelial nitric oxide synthase. J Cardiovasc Pharmacol 41: 474-480, 2003.
152. Woodman CR, Muller JM, Laughlin MH, and Price EM. Induction of nitric oxide synthase mRNA in coronary resistance arteries isolated from exercise-trained pigs. Am J Physiol Heart Circ Physiol 273: H2575-H2579, 1997.
153. Wu KK. Regulation of endothelial nitric oxide synthase activity and gene expression. Ann NY Acad Sci 962: 122-130, 2002.
154. Yoshizumi M, Perrella MA, Burnett JC Jr, and Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 73: 205-209, 1993.
155. Zembowicz A, Tang JL, and Wu KK. Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholine. J Biol Chem 270: 17006-17010, 1995.
156. Zhang J, Patel JM, and Block ER. Molecular cloning, characterization and expression of a nitric oxide synthase from porcine pulmonary artery endothelial cells. Comp Biochem Physiol B Biochem Mol Biol 116: 485-491, 1997.
157. Zhang MX, Ou H, Shen YH, Wang J, Coselli J, and Wang XL. Regulation of endothelial nitric oxide synthase by small RNA. Proc Natl Acad Sci USA 102: 16967-16972, 2005.